Working together with laboratories, Thermo Fisher Scientific played a critical role in helping to solve the world’s greatest challenges during the COVID‑19 pandemic. As a leader in the industry, we will continue to be here for you—delivering trusted molecular diagnostic solutions that help you guide effective patient outcomes.
Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices.
While traditional methods continue to have an important role in diagnosis of infectious diseases and other applications, PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.
Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.
CEO and Founder of Wise Diagnostic Systems shares insights on practical considerations when shifting from traditional methods to molecular technologies like PCR for infectious disease testing in the microbiology lab. We’ve captured this information in various ways; click on the buttons below.
Molecular diagnostic testing for viral hepatitis can be used to confirm hepatitis infection when serology results are unclear, and to monitor viral load levels.
A compilation of informative interviews with key medical experts, this is intended to aid lab professionals and clinicians working in all types of laboratories to better understand the clinical value of molecular testing.
This comprehensive HIV learning guide is offered with case studies in four modules and is edited by HIV healthcare experts from Senegal, Nigeria, India, and Brazil.